Klk Capital Management LLC Natera, Inc. Transaction History

Klk Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$86.26 - $119.0 $1.75 Million - $2.42 Million	-20,322 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$100.17 - $126.36 $370,528 - $467,405	3,699 Added 22.25%	20,322 $2.27 Million
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $1.43 Million - $1.99 Million	16,623 New	16,623 $1.89 Million

513

121M

412K

270K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $12.1B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Klk Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Klk Capital Management LLC with notifications on news.